Matthew Bonn
Dados Biográficos
| ID | 6094600 |
|---|---|
| NOME | Matthew Bonn |
| PRENOMES | Matthew |
| SOBRENOME | Bonn |
| ASSINATURA | BONN M |
| AFILIAÇÕES | Canadian Association of People Who Use Drugs, Dartmouth, Nova Scotia, Canada |
| ORCID | 0000-0002-6406-0171 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 18 |
| TOTAL DE CITAÇÕES | 5 |
| TOTAL COMO AUTOR | 18 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2020 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 1 |
Policing interactions and outcomes under shifting decriminalization policies in British Columbia
In January 2023, British Columbia (BC) implemented a three-year decriminalisation initiative, removing criminal sanctions for adults possessing up to 2.5 g of certain illegal drugs. In May 2024, the policy was amended, restoring penalties for possession in public spaces. Although these shifting legal frameworks may affect how people who use drugs experience policing, limited research has examined their perspectives. As part of a national evaluati…
A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
Safe(r) supply encompasses prescribed opioid alternatives interventions (safer supply) and non-medicalized (safe supply) approaches with shared antecedents but distinct attributes and consequences. This study highlights the need to better define and standardize the parameters of safer supply approaches, including population, dosing, and intended objectives, to enable a more precise assessment of their potential benefits and risks. This nuanced un…
A qualitative study exploring motives for the transition from injecting to smoking drugs in Vancouver, British Columbia
Experiences of stigmatization among people who use drugs in the initial year of British Columbia's drug decriminalization policy
While decriminalization has the potential to reduce stigma and increase comfort in accessing critical harm reduction and substance use treatment services among people who use drugs, achieving these outcomes requires additional efforts. Public awareness campaigns, targeted anti-stigma education, and broader systemic changes were suggested by participants as essential to address stigmatization in BC. Strengthening these areas could enhance access t…
Perceptions and experiences with police among people who use drugs in the initial year of British Columbia's decriminalization of illegal drugs policy
Research Summary On January 31, 2023, British Columbia (BC) launched a 3‐year pilot initiative decriminalizing the possession of up to 2.5 g of select illegal drugs. The policy aims to reduce stigma, address racial disparities in drug law enforcement, and improve police relations with people who use drugs (PWUD). As part of a national evaluation, we conducted qualitative interviews with 100 PWUD who reported using drugs at least three times a wee…
The decriminalization of illicit drugs in British Columbia
This evaluation will draw on implementation science research practices to evaluate and understand the full impacts of this novel drug policy experiment. Results will be widely disseminated through manuscripts, reports, presentations, and infographics, which will be adapted and tailored for specific audiences. The protocol identifies several anticipated challenges and limitations. This evaluation's evidence-based findings will be poised to offer p…
Defining a public health approach to substance use
Empirically unpacking multi-stakeholder understandings of a PHA to substance use can help to inform a more cohesive definition and build the consensus needed for more effective, coordinated, and community-led responses to substance use. Future work, especially qualitative research, will provide richer and more practical understandings of a PHA to substance use
Barriers to opioid use disorder treatment
Introduction: Medications such as buprenorphine and methadone are effective for treating opioid use disorder (OUD), but many patients face barriers related to treatment and access. We analyzed two sources of data-social media and published literature-to categorize and quantify such barriers. Methods: In this mixed methods study, we analyzed social media (Reddit) posts from three OUD-related forums (subreddits): r/suboxone, r/Methadone, and r/nalt…
A Preliminary Assessment of Short-Term Social and Substance Use-Related Outcomes Among Clients of Integrated Safer Opioid Supply Pilot Programs in Toronto, Canada
The online version contains supplementary material available at 10.1007/s11469-023-01219-3
Challenges of implementing safer supply programs in Canada during the Covid-19 pandemic
Safer supply pilot programs in Canada face multiple inner and outer implementation challenges. Given the potential role of safer supply programs in addressing the drug toxicity crisis in Canada and the possibility of future scale-up, services should be well-supported during their implementation phases. Refining service provision within safer supply programs based on the feedback and experiences of clients and program administrators is warranted, …
Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections
Risk of injecting-related bacterial infections varies greatly within-individuals over time. Risk is raised immediately after prison release, and around initiation and discontinuation of OAT. Social contextual factors likely contribute to excess risks at transitions in incarceration and OAT exposure
Spotting as a risk mitigation method
The increase in benzodiazepine-laced drugs and related risks in Canada
The overdose crisis in Canada has continuously evolved and is increasingly challenging to contain, while efforts from governments and policymakers to address it have often fallen short and resulted in unintended consequences. One of the main repercussions has been an unprecedented rise in adulterants in the illegal drug supply, including a wide array of pharmacological and psychoactive compounds and chemicals, which has resulted in a progressivel…
Criminalization Causes the Stigma”
Introduction In light of North America's persisting drug toxicity crisis, alternative drug policy approaches such as decriminalization, legalization, regulation, and safer supply have increasingly come to the forefront of drug policy discourse. The views of people who use drugs toward drug policy and drug law reform in the Canadian context are essential, yet largely missing from the conversation. The aim of this study was to capture the opinions,…
The Need for Evidence-based Harm Reduction Services in Correctional Facilities During the Covid-19 Pandemic
It is time for us all to embrace person-centred language for people in prison and people who were formerly in prison
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs
Addressing the Syndemic of HIV, Hepatitis C, Overdose, and Covid-19 Among People Who Use Drugs
People who use drugs (PWUD) face concurrent public health emergencies from overdoses, HIV, hepatitis C, and COVID-19, leading to an unprecedented syndemic. Responses to PWUD that go beyond treatment--such as decriminalization and providing a safe supply of pharmaceutical-grade drugs--could reduce impacts of this syndemic. Solutions already implemented for COVID-19, such as emergency safe-supply prescribing and providing housing to people experien…
Criminalization Causes the Stigma”
Introduction In light of North America's persisting drug toxicity crisis, alternative drug policy approaches such as decriminalization, legalization, regulation, and safer supply have increasingly come to the forefront of drug policy discourse. The views of people who use drugs toward drug policy and drug law reform in the Canadian context are essential, yet largely missing from the conversation. The aim of this study was to capture the opinions,…
Addressing the Syndemic of HIV, Hepatitis C, Overdose, and Covid-19 Among People Who Use Drugs
People who use drugs (PWUD) face concurrent public health emergencies from overdoses, HIV, hepatitis C, and COVID-19, leading to an unprecedented syndemic. Responses to PWUD that go beyond treatment--such as decriminalization and providing a safe supply of pharmaceutical-grade drugs--could reduce impacts of this syndemic. Solutions already implemented for COVID-19, such as emergency safe-supply prescribing and providing housing to people experien…
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs
The Need for Evidence-based Harm Reduction Services in Correctional Facilities During the Covid-19 Pandemic
It is time for us all to embrace person-centred language for people in prison and people who were formerly in prison
Barriers to opioid use disorder treatment
Introduction: Medications such as buprenorphine and methadone are effective for treating opioid use disorder (OUD), but many patients face barriers related to treatment and access. We analyzed two sources of data-social media and published literature-to categorize and quantify such barriers. Methods: In this mixed methods study, we analyzed social media (Reddit) posts from three OUD-related forums (subreddits): r/suboxone, r/Methadone, and r/nalt…
A Preliminary Assessment of Short-Term Social and Substance Use-Related Outcomes Among Clients of Integrated Safer Opioid Supply Pilot Programs in Toronto, Canada
The online version contains supplementary material available at 10.1007/s11469-023-01219-3
Challenges of implementing safer supply programs in Canada during the Covid-19 pandemic
Safer supply pilot programs in Canada face multiple inner and outer implementation challenges. Given the potential role of safer supply programs in addressing the drug toxicity crisis in Canada and the possibility of future scale-up, services should be well-supported during their implementation phases. Refining service provision within safer supply programs based on the feedback and experiences of clients and program administrators is warranted, …
Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections
Risk of injecting-related bacterial infections varies greatly within-individuals over time. Risk is raised immediately after prison release, and around initiation and discontinuation of OAT. Social contextual factors likely contribute to excess risks at transitions in incarceration and OAT exposure
Spotting as a risk mitigation method
The increase in benzodiazepine-laced drugs and related risks in Canada
The overdose crisis in Canada has continuously evolved and is increasingly challenging to contain, while efforts from governments and policymakers to address it have often fallen short and resulted in unintended consequences. One of the main repercussions has been an unprecedented rise in adulterants in the illegal drug supply, including a wide array of pharmacological and psychoactive compounds and chemicals, which has resulted in a progressivel…
Criminalization Causes the Stigma”
Introduction In light of North America's persisting drug toxicity crisis, alternative drug policy approaches such as decriminalization, legalization, regulation, and safer supply have increasingly come to the forefront of drug policy discourse. The views of people who use drugs toward drug policy and drug law reform in the Canadian context are essential, yet largely missing from the conversation. The aim of this study was to capture the opinions,…
The decriminalization of illicit drugs in British Columbia
This evaluation will draw on implementation science research practices to evaluate and understand the full impacts of this novel drug policy experiment. Results will be widely disseminated through manuscripts, reports, presentations, and infographics, which will be adapted and tailored for specific audiences. The protocol identifies several anticipated challenges and limitations. This evaluation's evidence-based findings will be poised to offer p…
Defining a public health approach to substance use
Empirically unpacking multi-stakeholder understandings of a PHA to substance use can help to inform a more cohesive definition and build the consensus needed for more effective, coordinated, and community-led responses to substance use. Future work, especially qualitative research, will provide richer and more practical understandings of a PHA to substance use
A qualitative study exploring motives for the transition from injecting to smoking drugs in Vancouver, British Columbia
Experiences of stigmatization among people who use drugs in the initial year of British Columbia's drug decriminalization policy
While decriminalization has the potential to reduce stigma and increase comfort in accessing critical harm reduction and substance use treatment services among people who use drugs, achieving these outcomes requires additional efforts. Public awareness campaigns, targeted anti-stigma education, and broader systemic changes were suggested by participants as essential to address stigmatization in BC. Strengthening these areas could enhance access t…
Perceptions and experiences with police among people who use drugs in the initial year of British Columbia's decriminalization of illegal drugs policy
Research Summary On January 31, 2023, British Columbia (BC) launched a 3‐year pilot initiative decriminalizing the possession of up to 2.5 g of select illegal drugs. The policy aims to reduce stigma, address racial disparities in drug law enforcement, and improve police relations with people who use drugs (PWUD). As part of a national evaluation, we conducted qualitative interviews with 100 PWUD who reported using drugs at least three times a wee…
Policing interactions and outcomes under shifting decriminalization policies in British Columbia
In January 2023, British Columbia (BC) implemented a three-year decriminalisation initiative, removing criminal sanctions for adults possessing up to 2.5 g of certain illegal drugs. In May 2024, the policy was amended, restoring penalties for possession in public spaces. Although these shifting legal frameworks may affect how people who use drugs experience policing, limited research has examined their perspectives. As part of a national evaluati…
A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
Safe(r) supply encompasses prescribed opioid alternatives interventions (safer supply) and non-medicalized (safe supply) approaches with shared antecedents but distinct attributes and consequences. This study highlights the need to better define and standardize the parameters of safer supply approaches, including population, dosing, and intended objectives, to enable a more precise assessment of their potential benefits and risks. This nuanced un…
HIV, Drug Use, Sexual Risk (14 obras) · Medicine (14 obras) · Opioid Use Disorder Treatment (11 obras) · Political science (9 obras) · Nursing (7 obras) · Psychiatry (7 obras) · Public health (7 obras) · Decriminalization (6 obras) · Harm reduction (6 obras) · Psychology (6 obras)